India's Concord Biotech surges over 21% in pre-open debut trade

Concord Biotech

18/08/2023 05:19

BENGALURU, Aug 18 (Reuters) - Shares of Indian biopharma
company Concord Biotech  CONB.NS  pre-opened 21.5% higher at
900.05 rupees ($10.83) in debut trading on Friday, compared with
the initial public offer (IPO) price of 741 rupees.   

($1 = 83.1025 Indian rupees)

 (Reporting by Rama Venkat in Bengaluru; Editing by Janane
Venkatraman)
 ((ramavenkat.raman@thomsonreuters.com; https://twitter.com/ramavenkat0607;
 +91 8095218099;))